PeptideDB

WWL229

CAS No.: 1338575-28-2

WWL229 is a selective inhibitor of Ces3 . WWL229 acts by inhibiting recombinant Ces3 but not Ces1f, ABHD6 or other teste
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description WWL229 is a selective inhibitor of Ces3 . WWL229 acts by inhibiting recombinant Ces3 but not Ces1f, ABHD6 or other tested serine hydrolases, and recapitulating the effects of WWL113 in adipocytes.
molecular weight 322.36
Molecular formula C16H22N2O5
CAS 1338575-28-2
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 60 mg/mL (186.13 mM)
References 1. Sun K . A Unique Role of Carboxylesterase 3 (Ces3) in β-Adrenergic Signaling Stimulated Thermogenesis. 2019. 2. Inactivation of CES1 Blocks Prostaglandin D2 Glyceryl Ester Catabolism in Monocytes/Macrophages and Enhances Its Anti-inflammatory Effects, Whereas the Pro-inflammatory Effects of Prostaglandin E2 Glyceryl Ester Are Attenuated[J]. ACS Omega, 2020, 5(45):29177-29188.